A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Bevacizumab + Tax In Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
APC8015 and Bevacizumab in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2